• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, September 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

New data changes the way scientists explain how cancer tumors develop

Bioengineer by Bioengineer
May 21, 2018
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

GALVESTON, Texas – A collaborative research team has uncovered new information that more accurately explains how cancerous tumors grow within the body. This study is currently available in Nature Genetics.

Researchers led by scientists at The University of Texas Medical Branch at Galveston and Baylor College of Medicine found that a losing a section of messenger RNA that was previously thought to transform normal cells into cancerous ones actually acts by blocking a body's ability suppress the formation of tumors. The finding could completely alter the way that medical science approaches the formation of tumors.

In molecules throughout the body, the three-prime untranslated region, or 3'UTR, is a section of messenger RNA that can alter gene expression. It's known that shortening this RNA section promotes cancerous tumor growth.

"Researchers have historically thought that this was because 3'UTR shortening induces the expression of proto-oncogenes, normal genes that when altered by mutation or expressed too high, become oncogenes that can transform a normal cell into a cancer cell," said Eric Wagner, UTMB associate professor in the department of biochemistry and molecular biology. "However, using a combination of computational approaches and cancer cell models, we found that 3'UTR shortening in tumors actually causes tumor-suppressing genes to be turned off."

In the study, the researchers used "Big data" analyses to reconstruct the RNA thought to form global regulatory networks within breast tumor cells and their matched normal tissues. This approach identified the fact that 3'UTRs are vital in regulating these global regulatory networks. Using this new information, they then disrupted these networks within breast cancer cells to test the effects on tumor growth.

###

Other authors include UTMB's Ping Ji, David Baillat and Camila Fontes-Garfias; Hyun Jung Park, Zheng Xia, Benjamin Rodriguez, Lei Li, Jianzhong Su, Kaifu Chen, Joel Neilson and Wei Li from Baylor College of Medicine; Soyeon Kim from the University of Texas Health Science Center at Houston; Chioniso Masamha From Butler University as well as Ann-Bin Shyu from the University of Texas McGovern Medical School.

Media Contact

Donna Ramirez
[email protected]
409-772-8791
@utmb_news

http://www.utmb.edu

https://www.utmb.edu/newsroom/article11771.aspx

Share12Tweet7Share2ShareShareShare1

Related Posts

Tumor Microenvironment Dynamics in Breast Cancer Therapy

September 13, 2025

Blocking Tumors: PD-L1 siRNA Boosts Immunotherapy

September 13, 2025

Non-Coding RNAs Crucial in Topotecan Cancer Response

September 13, 2025

Delayed Diagnosis Offers No Harm to Intussusception Success

September 13, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges

    153 shares
    Share 61 Tweet 38
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    116 shares
    Share 46 Tweet 29
  • Physicists Develop Visible Time Crystal for the First Time

    65 shares
    Share 26 Tweet 16
  • A Laser-Free Alternative to LASIK: Exploring New Vision Correction Methods

    49 shares
    Share 20 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Adverse Events in Asian Adults on Brivaracetam

Tumor Microenvironment Dynamics in Breast Cancer Therapy

Extraction Methods Impact Idesia Polycarpa Oil Quality

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.